Expert Review of Hematology, Volume 13, Issue 5 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 13, Issue 5 (2020)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Volume 13, 2020 Vol 12, 2019 Vol 11, 2018 Vol 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Drug Profile

Article
A critical evaluation of pembrolizumab in addition to lenalidomide and dexamethasone for the treatment of multiple myeloma
Albert Oriol
Pages: 435-445
Published online: 21 Mar 2020
AbstractforA critical evaluation of pembrolizumab in addition to lenalidomide and dexamethasone for the treatment of multiple myeloma | Full Text | References | PDF (968.3 KB) | EPUB
  • 413 Views
  • 5 CrossRef citations
  • 0Altmetric

Perspective

Cui bono? Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromes
Rory M. Shallis, Nikolai A. Podoltsev, Lohith Gowda, Amer M. Zeidan & Steven D. Gore
Pages: 447-460
Published online: 29 Mar 2020
AbstractforCui bono? Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromes | Full Text | References | PDF (1.1 MB) | EPUB
  • 109 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents
Andrés Gómez-De León, Luis Mario Villela-Martínez, José Miguel Yáñez-Reyes & David Gómez-Almaguer
Pages: 461-470
Published online: 10 Apr 2020
AbstractforAdvances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents | Full Text | References | PDF (1.1 MB) | EPUB
  • 353 Views
  • 6 CrossRef citations
  • 0Altmetric
Risk assessment of venous thromboembolism in hematological cancer patients: a review
Thomas Sau-Yan Chan, Yu Yan Hwang & Eric Tse
Pages: 471-480
Published online: 17 Apr 2020
AbstractforRisk assessment of venous thromboembolism in hematological cancer patients: a review | Full Text | References | PDF (870.7 KB) | EPUB
  • 262 Views
  • 3 CrossRef citations
  • 0Altmetric
An update on disease biomarkers for Hodgkin lymphoma
Melita Cirillo & Sven Borchmann
Pages: 481-488
Published online: 02 Apr 2020
AbstractforAn update on disease biomarkers for Hodgkin lymphoma | Full Text | References | PDF (653.1 KB) | EPUB
  • 307 Views
  • 2 CrossRef citations
  • 0Altmetric
Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits
Rory M. Shallis, Maximilian Stahl, Jan Philipp Bewersdorf, Jeanne E. Hendrickson & Amer M. Zeidan
Pages: 489-499
Published online: 17 Apr 2020
AbstractforLeukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits | Full Text | References | PDF (1 MB) | EPUB
  • 458 Views
  • 21 CrossRef citations
  • 0Altmetric
Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence
Pellegrino Musto & Francesco La Rocca
Pages: 501-517
Published online: 17 Apr 2020
AbstractforMonoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence | Full Text | References | PDF (1.2 MB) | EPUB
  • 279 Views
  • 4 CrossRef citations
  • 0Altmetric
Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape
Roman M. Shapiro & Joseph H. Antin
Pages: 519-532
Published online: 19 Apr 2020
AbstractforTherapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape | Full Text | References | PDF (1.1 MB) | EPUB
  • 1552 Views
  • 17 CrossRef citations
  • 0Altmetric
Enhancing CAR T cell efficacy: the next step toward a clinical revolution?
Manjusha Namuduri & Renier J. Brentjens
Pages: 533-543
Published online: 27 Apr 2020
AbstractforEnhancing CAR T cell efficacy: the next step toward a clinical revolution? | Full Text | References | PDF (1 MB) | EPUB
  • 547 Views
  • 10 CrossRef citations
  • 0Altmetric

Original Research

Article
Clinical spectrum, risk factors, management and outcome of patients with retroperitoneal hematoma: a retrospective analysis of 3-year experience
Kamal Kant Sahu, Ajay Kumar Mishra, Amos Lal, Susan V. George & Ahmad Daniyal Siddiqui
Pages: 545-555
Published online: 03 Mar 2020
AbstractforClinical spectrum, risk factors, management and outcome of patients with retroperitoneal hematoma: a retrospective analysis of 3-year experience | Full Text | References | PDF (1.7 MB) | EPUB
  • 310 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017
Darshana Durup, Philip Schaffalitzky de Muckadell & Claes Christian Strom
Pages: 557-564
Published online: 17 Mar 2020
AbstractforEvaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017 | Full Text | References | PDF (811.1 KB) | EPUB | Supplemental
  • 3537 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Article
Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis
Li Hui, Li Qi, Hu Guoyu, Shen Xuliang & Tan Meiao
Pages: 565-575
Published online: 21 Mar 2020
AbstractforRuxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 677 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?
Betül Saydan et al.
Editorial | Published online: 25 Jun 2024
Free Access
Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors
Kazuo Sakashita et al.
Review Article | Published online: 25 Jun 2024
Optimising salvage therapy for Hodgkin lymphoma: progress and future challenges
Chathuri Abeyakoon et al.
Review Article | Published online: 25 Jun 2024
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women
Lydia H. Pecker et al.
Review Article | Published online: 24 Jun 2024
View all latest articles